Profile data is unavailable for this security.
About the company
Mauna Kea Technologies SA formerly Mauna Kea Technologies SAS is a France-based medical device manufacturing company. The Company specializes in designing, developing, and selling optical biopsy devices and tools. Its products are intended for visualizing and detecting cellular abnormalities during the gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. It provides Cellvizio product that is used by medical specialties and is revolutionizing the way physicians diagnose and treat patients making a transformative change in medicine. Its real-time in vivo cellular imaging platform, that delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time.
- Revenue in EUR (TTM)10.48m
- Net income in EUR-3.73m
- Incorporated2000
- Employees68.00
- LocationMauna Kea Technologies SA9, rue d'EnghienPARIS 75010FranceFRA
- Phone+33 148240345
- Fax+33 148241218
- Websitehttps://www.maunakeatech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spineguard SA | 4.31m | -4.18m | 11.97m | 24.00 | -- | 1.98 | -- | 2.77 | -0.1084 | -0.1084 | 0.1118 | 0.1270 | 0.3827 | 1.28 | 4.68 | 179,700.00 | -37.12 | -23.69 | -52.43 | -42.73 | 72.89 | 75.60 | -97.00 | -45.02 | 1.73 | -13.51 | 0.3384 | -- | -22.98 | -10.65 | -74.81 | -- | 89.42 | -- |
| Laboratoires Euromedis SA | 49.54m | -5.51m | 13.05m | 194.00 | -- | 0.4679 | -- | 0.2635 | -1.84 | -1.84 | 16.46 | 9.70 | 0.8283 | 3.54 | 4.88 | 255,371.10 | -9.19 | -- | -11.45 | -- | 32.67 | -- | -11.09 | -- | 3.57 | -12.83 | 0.2875 | -- | -51.58 | -- | -362.99 | -- | -- | -- |
| Implanet SA | 7.45m | -6.68m | 13.68m | 41.00 | -- | -- | -- | 1.84 | -0.1704 | -0.1704 | 0.1933 | -0.0042 | 0.5931 | 0.9083 | 4.19 | 182,973.00 | -53.17 | -37.44 | -159.90 | -86.74 | 56.83 | 59.59 | -89.65 | -67.43 | 0.2932 | -24.76 | 1.03 | -- | -7.24 | 2.08 | -88.59 | -- | -2.20 | -- |
| Theraclion SA | 1.87m | -4.88m | 17.15m | 30.00 | -- | 2.53 | -- | 9.17 | -0.1362 | -0.1362 | 0.0504 | 0.1481 | 0.1021 | 0.282 | 1.23 | 66,785.00 | -26.65 | -40.08 | -35.36 | -59.96 | 54.21 | 52.19 | -260.94 | -276.13 | 2.50 | -56.17 | 0.2546 | -- | -16.58 | -12.66 | -32.02 | -- | 11.77 | -- |
| Diagnostic Medical Systems SA | 42.15m | -9.76m | 18.55m | 147.00 | -- | 1.46 | -- | 0.4401 | -0.4982 | -0.2481 | 2.23 | 0.7023 | 0.8027 | 1.81 | 6.81 | 286,755.10 | -18.73 | -12.33 | -33.53 | -22.14 | 37.58 | 37.72 | -23.33 | -16.45 | 0.7105 | -3.52 | 0.5938 | -- | 19.51 | 11.62 | -106.30 | -- | -- | -- |
| Alpha Mos SA | 6.16m | -3.39m | 18.66m | 48.00 | -- | -- | -- | 3.03 | -0.3105 | -0.3105 | 0.5637 | -0.5066 | 0.8424 | 2.24 | 4.99 | 128,270.80 | -46.70 | -50.01 | -481.38 | -102.49 | 71.27 | 68.37 | -55.43 | -74.15 | 0.4423 | -10.76 | 11.30 | -- | 2.25 | 7.46 | -39.13 | -- | 7.59 | -- |
| Mauna Kea Technologies SA | 10.48m | -3.73m | 25.01m | 68.00 | -- | -- | -- | 2.39 | -0.0578 | -0.0578 | 0.2126 | -0.2809 | 0.4905 | 2.31 | 2.45 | 154,117.60 | -17.45 | -51.23 | -223.84 | -93.30 | 33.62 | 11.15 | -35.57 | -142.41 | 0.4287 | 4.29 | 2.38 | -- | 40.13 | 9.16 | 66.66 | -- | -21.16 | -- |
| Affluent Medical SAS | 0.00 | -15.65m | 55.85m | 52.00 | -- | -- | -- | -- | -0.5828 | -0.5828 | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -23.85 | -- | -- | -- | -- | -2.80 | -- | -- | -- |
| Novacyt SA | 9.25m | -29.74m | 56.27m | 222.00 | -- | 0.446 | -- | 6.08 | -0.421 | -0.4224 | 0.131 | 1.79 | 0.0528 | 1.33 | 0.2622 | 41,676.88 | -16.96 | 17.69 | -20.71 | 23.82 | 43.21 | 62.82 | -321.40 | 23.87 | 4.98 | -79.02 | 0.0036 | 0.00 | -77.28 | 13.49 | -269.46 | -- | -13.46 | -- |
| Visiomed Group SA | 13.71m | 902.00k | 59.35m | 94.00 | 0.1205 | 2.36 | 10.71 | 4.33 | 1.60 | 1.60 | 0.0383 | 0.0819 | 0.3772 | 2.40 | 9.07 | 145,808.50 | 2.48 | -29.88 | 2.84 | -57.19 | 94.24 | 51.88 | 6.57 | -59.42 | 1.71 | 0.2127 | 0.2426 | -- | -5.12 | 9.42 | 117.09 | -- | 27.51 | -- |
| Carmat SA | 2.80m | -53.87m | 105.79m | 182.00 | -- | -- | -- | 37.82 | -2.18 | -2.18 | 0.1128 | -1.09 | 0.0405 | 1.63 | 0.6353 | 15,368.13 | -77.90 | -76.92 | -97.48 | -94.38 | -1,109.12 | -- | -1,925.92 | -4,636.64 | 1.19 | -17.09 | 1.88 | -- | 710.72 | -- | -0.3502 | -- | 16.99 | -- |
Data as of May 29 2024. Currency figures normalised to Mauna Kea Technologies SA's reporting currency: Euro EUR
2.34%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| OFI Invest Asset Management SAas of 29 Feb 2024 | 712.09k | 1.16% |
| UBS LA MAISON de Gestionas of 30 Dec 2022 | 675.00k | 1.10% |
| Pure Capital SAas of 30 Jun 2023 | 55.00k | 0.09% |
Data from 31 Dec 2023 - 30 Apr 2024Source: FactSet Research Systems Inc.
